↓ Skip to main content

Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment – real world outcomes

Overview of attention for article published in The Journal of Headache and Pain, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
twitter
6 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment – real world outcomes
Published in
The Journal of Headache and Pain, January 2021
DOI 10.1186/s10194-020-01214-2
Pubmed ID
Authors

J. Talbot, R. Stuckey, L. Crawford, S. Weatherby, S. Mullin

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 19%
Student > Bachelor 6 12%
Researcher 6 12%
Student > Ph. D. Student 4 8%
Unspecified 2 4%
Other 6 12%
Unknown 18 35%
Readers by discipline Count As %
Medicine and Dentistry 14 27%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Neuroscience 5 10%
Nursing and Health Professions 3 6%
Psychology 2 4%
Other 4 8%
Unknown 19 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2021.
All research outputs
#2,469,171
of 23,849,058 outputs
Outputs from The Journal of Headache and Pain
#290
of 1,417 outputs
Outputs of similar age
#68,640
of 506,497 outputs
Outputs of similar age from The Journal of Headache and Pain
#8
of 14 outputs
Altmetric has tracked 23,849,058 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,417 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 506,497 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.